ERLANGER MEDICAL CENTER — History
CCN 440104 | 3-year financial timeline | COVID resilience: 60/100
🛡️ Public data only — no PHI permitted on this instance.
$1.1B
Latest Revenue (FY2022)
+7.7%
Revenue CAGR (3yr)
-6.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $938M | $991M | $1.1B | +9.8% | +7.7% |
| Operating Expenses | $962M | $1.0B | $1.2B | +11.1% | +9.7% |
| Operating Margin | -2.5% | -5.1% | -6.4% | -25.7% | +0.0% |
| Net Income | $-23M | $-51M | $-70M | -38.0% | +0.0% |
| Licensed Beds | 688 | 691 | 750 | +8.5% | +4.4% |
| Total Patient Days | 182,809 | 170,140 | 162,902 | -4.3% | -5.6% |
| Medicare Day % | 19% | 15% | 14% | -6.7% | -14.0% |
| Medicaid Day % | 18% | 6% | 7% | +15.7% | -40.4% |
COVID Impact & Recovery
Resilience Score: 60/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +16.0% ($938M → $1.1B)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.7%
This Hospital
+7.6%
State Avg
Latest Margin
-6.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $1.2B | -8.4% |
| FY2024 (proj) | $1.2B | -10.3% |
| FY2025 (proj) | $1.3B | -12.3% |